Tilray Brands Income from Continuous Operations 2017-2025 | TLRY
Tilray Brands income from continuous operations from 2017 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Tilray Brands Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025 | $-2,181 |
| 2024 | $-222 |
| 2023 | $-1,443 |
| 2022 | $-434 |
| 2021 | $-336 |
| 2020 | $-271 |
| 2020 | $-101 |
| 2019 | $-321 |
| 2018 | $-68 |
| 2017 | $-8 |
| 2017 | $-9 |
| 2016 | $-8 |
| 2016 | $-9 |
| Tilray Brands Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-05-31 | $-1,268 |
| 2025-02-28 | $-794 |
| 2024-11-30 | $-85 |
| 2024-08-31 | $-35 |
| 2024-05-31 | $-15 |
| 2024-02-29 | $-105 |
| 2023-11-30 | $-46 |
| 2023-08-31 | $-56 |
| 2023-05-31 | $-120 |
| 2023-02-28 | $-1,196 |
| 2022-11-30 | $-62 |
| 2022-08-31 | $-66 |
| 2022-05-31 | $-458 |
| 2022-02-28 | $52 |
| 2021-11-30 | $6 |
| 2021-08-31 | $-35 |
| 2021-05-31 | $353 |
| 2021-03-31 | $-341 |
| 2021-02-28 | $-259 |
| 2020-12-31 | |
| 2020-11-30 | $-89 |
| 2020-09-30 | $-2 |
| 2020-08-31 | $-22 |
| 2020-06-30 | $-82 |
| 2020-03-31 | $-184 |
| 2019-12-31 | |
| 2019-09-30 | $-36 |
| 2019-06-30 | $-36 |
| 2019-03-31 | $-29 |
| 2018-12-31 | $-58 |
| 2018-09-30 | $-19 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $-5 |
| 2018-02-28 | $-5 |
| 2017-12-31 | |
| 2017-11-30 | $-2 |
| 2017-09-30 | $-2 |
| 2017-08-31 | $-2 |
| 2017-06-30 | $-2 |
| 2017-05-31 | |
| 2017-03-31 | $-1 |
| 2017-02-28 | $-1 |
| 2016-11-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.167B | $0.821B |
| Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.506B | 27.03 |
| Boston Scientific (BSX) | United States | $157.140B | 37.47 |
| Stryker (SYK) | United States | $149.815B | 30.50 |
| EssilorLuxottica (ESLOY) | France | $148.753B | 0.00 |
| Medtronic (MDT) | Ireland | $119.490B | 16.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.052B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.480B | 25.41 |
| ResMed (RMD) | United States | $42.323B | 30.27 |
| Agilent Technologies (A) | United States | $33.835B | 22.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.726B | 15.85 |
| Terumo (TRUMY) | Japan | $27.731B | 32.86 |
| Koninklijke Philips (PHG) | Netherlands | $26.731B | 17.68 |
| Insulet (PODD) | United States | $23.441B | 78.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.941B | 13.33 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.385B | 0.00 |
| Baxter (BAX) | United States | $12.466B | 9.63 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.798B | 28.64 |
| Lantheus Holdings (LNTH) | United States | $3.817B | 10.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.443B | 24.09 |
| Perrigo (PRGO) | Ireland | $3.255B | 8.13 |
| Prestige Consumer Healthcare (PBH) | United States | $3.201B | 14.20 |
| ICU Medical (ICUI) | United States | $3.045B | 20.73 |
| Haemonetics (HAE) | United States | $2.623B | 11.71 |
| LeMaitre Vascular (LMAT) | United States | $2.189B | 46.95 |
| AtriCure (ATRC) | United States | $1.793B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.789B | 11.26 |
| Curaleaf Holdings (CURLF) | Canada | $1.750B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.687B | 72.46 |
| AdaptHealth (AHCO) | United States | $1.262B | 17.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Acuren (TIC) | United States | $1.220B | 0.00 |
| Neogen (NEOG) | United States | $1.210B | 19.21 |
| BioLife Solutions (BLFS) | United States | $1.196B | 2496.00 |
| Valneva SE (VALN) | France | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 8.30 |
| Kestra Medical Technologies (KMTS) | United States | $0.852B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.626B | 0.00 |
| SNDL (SNDL) | Canada | $0.581B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.557B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.535B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.528B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.466B | 16.04 |
| CeriBell (CBLL) | United States | $0.425B | 0.00 |
| Owens & Minor (OMI) | United States | $0.412B | 3.66 |
| Sanuwave Health (SNWV) | United States | $0.338B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.290B | 0.00 |
| Omeros (OMER) | United States | $0.285B | 0.00 |
| Brainsway (BWAY) | Israel | $0.279B | 56.81 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 20.18 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Quanterix (QTRX) | United States | $0.228B | 0.00 |
| Cerus (CERS) | United States | $0.222B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.201B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.47 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.34 |
| Biote (BTMD) | United States | $0.147B | 4.87 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.10 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 31.80 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 34.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.21 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.031B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |